Announced
Completed
Financials
Sources
Tags
Minority
Private
Completed
Cross Border
Acquisition
Friendly
Private Equity
Australia
drug development
provides phase i-iv clinical trial
clinical research organization
Pharmaceuticals
Test Inspection and Certification (TIC)
Synopsis
Investment managers Sequoia Capital and GIC led a $760m funding round in TPG Asia-backed Novotech, a clinical research and testing provider. The funding will support Novotech to pursue further growth opportunities through M&A in geographical expansion as well as data, AI, and tech-enabled offerings. “We look forward to accelerating our growth by pursuing various strategic M&A and tech enablement initiatives and seek to better serve our biotech and pharmaceutical clients and support the clinical research industry in the development of a wide spectrum of therapeutic areas,” John Moller, Novotech CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.